Background. The impact of pediatric 7-valent pneumococcal conjugate vaccination (PCV-7) on the population of Streptococcus pneumoniae in the United States was examined by determining the serotypes, antimicrobial resistance profiles, and genetic relatedness of isolates from patients with invasive and noninvasive infections during the 2004-2005 respiratory illness season.
Substantial decreases in the incidence of pneumococcal invasive disease were evident by [2001] [2002] in all age groups [7] [8] [9] . Decreases in invasive disease due to antimicrobial-resistant pneumococci have also been attributed to PCV-7 [10, 11] . However, the increase in the rate of infections caused by nonvaccine "replacement" strains is an ongoing concern [9, [12] [13] [14] [15] [16] [17] .
Longitudinal surveillance of isolates that cause pneumococcal disease provides useful information for assessing the impact of current vaccines and establishes a basis to guide future vaccine development. Data derived from the characterization of isolates of S. pneumoniae recovered from patients with localized respiratory infections are limited [18] . In this article, we describe the antimicrobial susceptibility profiles, serotype distribution, and genetic relatedness of S. pneumoniae isolates that caused invasive and noninvasive infections in the United States during the 2004-2005 respiratory illness season. These data are compared with previous studies that we conducted during the 1994-1995 and 1999-2000 respiratory illness seasons, before the introduction and widespread application of PCV-7 [3, 5] .
METHODS
A total of 1647 isolates of S. pneumoniae were characterized in this study. These organisms were recovered from patients in 41 . Each laboratory was asked to submit 50 consecutive, clinically significant pneumococcal isolates from unique patients. On receipt in the central laboratory, organisms were stored at Ϫ70ЊC on beads.
The identification of isolates was confirmed using the AccuProbe S. pneumoniae culture identification test (GenProbe). Capsular serotypes were determined with type-specific antisera (Statens Serum Institut).
Antimicrobial susceptibility testing was performed using the Clinical and Laboratory Standards Institute broth microdilution method in Mueller-Hinton broth with 3% lysed horse blood at a final inoculum concentration of approximately colony forming units per mL [19, 20] . Trays were in- 5 5 ϫ 10 cubated for 20-24 h in ambient air (air temperature, 35ЊC ‫ע‬ ) before determining MICs. S. pneumoniae ATCC 49619 2ЊC was used as a quality control strain. The multidrug resistance phenotype was defined as nonsusceptibility to penicillin (MIC, у0.12 mg/mL) and у2 other non-b-lactam antimicrobial classes.
In January 2008, the Clinical and Laboratory Standards Institute published new breakpoints for parenteral penicillin therapy of nonmeningitis (susceptible, р2 mg/mL; intermediate, 4 mg/mL; resistant, у8 mg/mL) and meningitis (susceptible, р0.06 mg/mL; resistant, у0.1 mg/mL) strains of S. pneumoniae, although the original breakpoints were retained for oral penicillin therapy of nonmeningitis isolates (susceptible, р0.06 mg/ mL; intermediate, 0.1-1 mg/mL; resistant, у2 mg/mL) [21] . For pneumococcal isolates recovered from specimens other than CSF, laboratories are advised to report meningitis and nonmeningitis interpretations. To avoid confusion, we applied the penicillin breakpoints that were used in previous studies and that were applicable during the surveillance periods (i.e., the current oral therapy nonmeningitis breakpoints) [21] . The penicillin nonsusceptible category is equivalent for oral nonmeningitis and parenteral meningitis isolates (у0.1 mg/mL).
PFGE was performed using a simplified protocol for S. pneumoniae [22] with use of SmaI (250 U/mL) restriction endonuclease digestion of DNA. The CHEF-DR II (Bio-Rad) instrument was used for electrophoresis with conditions of 200 V at 14ЊC for 20 h (initial forward time, 1 s; final forward time, 20 s). Ethidium bromide-stained gels were analyzed using Bionumerics software (Applied Maths). The unweighted pairedgroup method with arithmetic averages and Dice's coefficient (optimization, 1.0%; position tolerance, 1.0%) was used for dendrogram construction. Isolates that differed by р3 bands (dendrogram similarity coefficient, у84%) were assigned to the same PFGE type [23] . [24] .
The relationship of isolate serotype to specimen type, patient age group, resistance profile, and PFGE type was examined. The serotype distribution and genetic relatedness of the penicillin-resistant S. pneumoniae (PRSP) population (MIC, у2 mg/ mL) in 2004-2005 was compared with previously published results for PRSP isolates from 1994-1995 and 1999-2000 [3, 5] . Twenty-seven of the 41 laboratories in the 2004-2005 study also participated during the 1999-2000 surveillance period. Twenty-two of the 33 medical centers in the 1999-2000 study were part of the 1994-1995 surveillance project [3] . Fisher's 2-tailed exact test was used to assess the statistical significance of group proportion differences.
RESULTS
In 2004-2005, 32.5% of the pneumococcal isolates were nonsusceptible to penicillin (17.9% had an MIC 0.1-1 mg/mL; 14.6% had an MIC у2 mg/mL) (table 1). Rates of penicillin resistance varied by the specimen type from which isolates were obtained. Among isolates from blood specimens, 15.8% had NOTE. I, intermediate resistant; R, resistant, TMP-SMX, trimethoprim-sulfamethoxazole. MIC susceptibility categories for each antimicrobial agent are as follows: penicillin (I, 0.1-1 mg/mL; R, у2 mg/mL), amoxicillin (I, 4 mg/mL; R, у8 mg/mL), ceftriaxone (I, 1 mg/mL; R, у2 mg/mL), vancomycin (nonsusceptible, 11 mg/ml), erythromycin ( I, 0.5 mg/mL; R, у1 mg/mL), clindamycin (I, 0.5 mg/mL; R, у1 mg/mL), tetracycline (I, 4 mg/mL; R, у8 mg/mL), TMP-SMX (I, 1/19-2/38 mg/ mL; R, у4/76 mg/mL), ciprofloxacin (I, 4 mg/mL; R, у8 mg/mL), levofloxacin (I, 4 mg/mL; R, у8 mg/mL), moxifloxacin (I, 2 mg/mL; R, у4 mg/mL), and chloramphenicol (R, у8 mg/mL). Of the 1647 isolates obtained, 53% were from lower respiratory tract specimens, 13% were from upper respiratory tract specimens, and 26% were from invasive specimens (blood, CSF, or other normally sterile body fluid specimens). Middle ear specimens yielded more PCV-7-related serotype isolates (40.5%;
) and fewer PCV-7 serotypes (9.5%; P p .003 P p ) than did specimens from other sites ( ) and nontypeable isolates (2.6%; ) P ! .001 P p .009 than did other specimen types.
Most of the isolates (60%) were from inpatients; 38% were from outpatients. Twenty percent of patients were aged р5 years, 8% were aged 6-20 years, 47% were aged 21-64 years, 21% were aged у65 years, and 4% were of an unknown age. The serotype distribution of isolates was similar among age groups, with a few exceptions (data not shown). For patients ) than that among the overall P ! .001 isolate population, and fewer isolates were from blood culture specimens among PFGE C (10.8%; ), PFGE D (10.5%; P p .002 ), and PFGE E isolates (11.1%;
). The prev-P p .003 P p .005 alence of isolates from lower respiratory tract specimens was higher among PFGE D isolates (64.5%;
) and lower P p .04 among PFGE H isolates (28.1%;
) than that among P p .007 the general isolate population. The proportion of isolates from middle ear specimens was higher among PFGE C (20.5%; ) and PFGE E isolates (18%; ), and the fraction P ! .001 P p .002 of isolates from sinus specimens was higher among PFGE C isolates (12%;
) and lower among PFGE B isolates (1%; P p .02 ), compared with the overall isolate population. P p .04
The age distribution of patients from whom isolates were obtained among the predominant 8 PFGE types was similar to the overall isolate population, with a few exceptions. There was a greater proportion of isolates from patients aged 0-5 years among PFGE type C (34.9%;
) and type E isolates P p .001 (37.5%; ) than among the overall isolate population. P ! .001 Among patients aged 21-64 years, there were more PFGE H (81.3%;
) and fewer PFGE E isolates (34.7%; ), P ! .001 P p .04 compared with the distribution of isolates overall. A greater proportion of PFGE F isolates were from patients aged у65 years (34.8%; ) than that among the overall isolate P p .009 population.
Among the centers that submitted isolates, 28.5% of isolates were from the Northeast, 24.5% were from the Midwest, 17.1% were from the Southeast, 16.1% were from the Southwest, and 13.8% were from the West. Variation in the geographic distribution of isolates among the predominant 8 PFGE types was noted for PFGE C (increased proportion of isolates from Southeast, 26.5%;
) and PFGE G (increased proportion of P p .02 isolates from Northeast, 47.6%;
; decreased proportion P p .009 of isolates from the Midwest, 9.5%;
). P p .03 [5] . The distribution of PRSP strains among major PFGE types (i.e., those types including у5 isolates) has fluctuated during the study periods. In 1999-2000, 10 major PFGE types accounted for 78.4% of the PRSP population [5] . 
DISCUSSION

